紅塔證券(601236.SH):因實施配股 將於7月27日至8月3日停牌
格隆匯7月21日丨紅塔證券(601236.SH)公佈,因公司實施配股,擬向截至股權登記日(2021年7月26日)上海證券交易所收市後,在中國證券登記結算有限公司上海分公司登記在冊的公司全體A股股東按照每10股配售3股的比例向股東配售A股股份。
根據上海證券交易所的相關規定,2021年7月27日至2021年8月2日為本次配股繳款期,繳款期公司A股股票全天停牌;2021年8月3日為登記公司網上清算期,公司A股股票繼續停牌一天;公司A股股票將於2021年8月4日開市起復牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.